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Abstract
Cytotoxic T lymphocytes (CTL) are a major factor in the control of HIV replication. CTL arise in
acute infection causing escape mutations to spread rapidly through the population of infected cells. As a
result, the virus develops partial resistance to the immune response. The factors controlling the order of
mutating epitope sites are currently unknown and would provide a valuable tool for predicting conserved
epitopes. In this work, we adapt a well-established mathematical model of HIV evolution under dynamical
selection pressure from multiple CTL clones to include partial impairment of CTL recognition, ∆r, as well
as cost to viral replication, ∆f. The process of escape is described in terms of the cost-beneﬁt tradeoﬀ of
escape mutations and predicts a trajectory in the cost-beneﬁt plane connecting sequentially escaped sites,
which moves from high recognition loss/low ﬁtness cost to low recognition loss/high ﬁtness cost and has
a larger slope for early escapes than for late escapes. The slope of the trajectory oﬀers an interpretation
of positive correlation between ﬁtness costs and HLA binding impairment to HLA-A molecules and a
protective subset of HLA-B molecules that was observed for clinically relevant escape mutations in the2
Pol gene. We estimate the value of ∆r from published experimental studies to be in the range (0.01-0.86)
and show that the assumption of complete recognition loss (∆r = 1) leads to an overestimate of mutation
cost. Our analysis oﬀers a consistent interpretation of the commonly observed pattern of escape, in which
several escape mutations are observed transiently in an epitope. This non-nested pattern is a combined
eﬀect of temporal changes in selection pressure and partial recognition loss. We conclude that partial
recognition loss is as important as ﬁtness loss for predicting the order of escapes and, ultimately, for
predicting conserved epitopes that can be targeted by vaccines.
Author Summary
Like many viruses, HIV has evolved mechanisms to evade the host immune response. As early as a
few weeks after infection is initiated, mutations appear in the viral genome that reduce the ability of
cytotoxic T lymphocytes (CTL) to control virus replication. However, of the many mutations in the
viral genome that could potentially mediate viral escape from the CTL response, a speciﬁc subset are
typically observed. This suggests that some mutations either entail too high a ﬁtness cost for the virus, or
are relatively ineﬃcient escape mutations. A successful vaccine would target the CTL response to these
regions in such a way that escape would not be possible. We use a computational model of HIV infection
in order to study the factors that determine whether a given escape mutation will occur, how long it
will be maintained in the population, and how these changes in the viral genome will aﬀect the CTL
response. Our analysis highlights the important role of partial recognition loss conferred by a mutation
in producing the complex dynamics of escape that are observed during the course of infection.
Introduction
HIV replication continues for years despite a highly active immune response. Depletion of cytotoxic CD8+
T cells (CTL) in SIV infected animals causes rapid increase in viremia [1,2] showing that CTL control
HIV/SIV replication; that this response is antigen-speciﬁc is evident from rapid genetic evolution of HIV
in antigenically important regions. Antigenic escape is one of the major mechanisms of HIV resilience in
face of an active immune response, impeding eﬀective vaccine design [3] and implicated in the progression
to AIDS [4]. Shortly after infection is initiated, many CTL clones arise to target the transmitted virus3
strain [5–7], each clone recognizing a distinct 8-10 amino acid viral peptide (epitope) presented on the
surface of an infected cell by MHC molecules. Escape mutations in CTL epitopes begin to be selected
within a month of infection and continue to be selected throughout chronic infection, sometimes causing
a decrease in the intrinsic replication rate of the virus (ﬁtness cost) [8–10]. However, despite a sustained
CTL response, not all targeted epitopes escape. Moreover, among epitopes that do escape, the rate of
escape slows dramatically over the ﬁrst 100 days post infection. It remains unclear which parameters
decide the timing and rate of escape in a given epitope as well as which epitopes escape and which are
preserved throughout chronic infection [11–13].
Mathematical models of HIV evolution in the presence of multiple CTL clones have been applied to
study the emergence of late escape mutations [14,15] and the eﬀect of distributed CTL pressure on the rate
of escape [12,16]. Previous work has emphasized two parameters, the mutation cost (∆f) and the number
of active epitopes (n). It can be inferred that escape mutations come at a cost from the observation
of occasional reversion of escape mutations upon transmission between MHC mismatched individuals
[8,9,17,18], as well as the frequent acquisition of compensatory mutations outside the epitope [19,20].
Common escape mutations have been shown experimentally to have wide ranging ﬁtness costs [10,21,22].
However, ﬁtness costs and the number of CTL clones acting on the virus are not the sole determinants of
the dynamics of escape. It has been observed in HIV infected individuals [23] and SIV infected animals [24]
that CTL are capable of recognizing diﬀerent variants of an epitope with diﬀerent eﬃciencies. Thus, in
general, an escape mutant does not fully abrogate recognition of the corresponding CTL clone.
In the present work, we address the process of antigenic escape in terms of a cost-beneﬁt diagram.
The beneﬁt of an escape mutation is a partial CTL recognition loss and the mutation cost is a partial
reduction in viral replication rate. We extend the basic model introduced by Althaus and De Boer [14]
to include partially eﬀective escape mutations and investigate how the two opposing evolutionary forces
together determine the observed rate of escape from the CTL response [12,25]. The model predicts that a
positive correlation between recognition and ﬁtness losses emerges during sequential escape mutations, the
strength of which changes over time as pressure from the immune system wanes. We compare our model
predictions with existing data showing a correlation between ﬁtness and recognition losses in clinically
relevant escape mutations from the Pol gene [26] and estimate the range of recognition losses that occurs
in commonly observed escape mutations from three published studies [27–29].
Furthermore, the inclusion of partially eﬀective escape mutations in the model can reproduce the4
diverse patterns of intra-epitope escape that are routinely observed in HIV infected patients. During the
majority of escape mutations that have been studied with time-resolved viral sequencing, 2-10 distinct
epitope sequences grow in number to replace the transmitted sequence and eventually one mutant epitope
spreads to the entire population. Furthermore, the dominant mutated epitope sequence changes over
time [11, 30, 31]. Although, in some epitopes, mutations are added at new sites in a nested fashion,
in a larger number of epitopes, mutations at new sites replace mutations at previous sites leading to
a non-nested pattern. This pattern is atypical for models assuming constant selection pressure. The
analysis below illustrates how time-dependent selection due to the changing CTL pressure and partial
CTL recognition loss can produce the non-nested pattern of escape (see [32] for review).
Results
Phases of HIV infection
In order to study escape from a the immune response we consider a model that includes target cells,
infected cells and multiple CTL clones which recognize various regions (epitopes) in the viral genome
with equal avidities (Figure 1A and Model). The model predicts three distinct phases of HIV infection
(Figure 1B), as follows. Phase 1: The transmitted HIV strain expands in the population of target cells.
Phase 2: All CTL clones that recognize cells infected by the transmitted strain are activated, expand,
and reduce the number of infected cells. A steady state is obtained with constant levels of infected cells
and CTL, which represents chronic HIV infection (see Equations S1-S3 in Text S1). Phase 3: Escape
mutations in viral epitopes emerge, changing the genetic composition of the population of infected cells
and the clonal composition of the CTL population but only weakly aﬀecting their overall sizes.
The dynamics of infected cells and CTL during the escape phase (Phase 3) depends on the number
of epitopes that are targeted, n, and on the degree of recognition loss per mutation, ∆r (Table 1). In
the simplest case, if a single CTL clone is present in steady state and an escape mutation arises which
completely abrogates CTL recognition (∆r = 1), the CTL clone contracts and the population of infected
cells containing the escape mutation grows uncontrolled until target cells are depleted. In contrast, if the
recognition loss conferred by the escape mutation is partial (∆r<1), the population of infected cells
grows only transiently, and the CTL clone expands until a new steady state is reached. When a group of
CTL clones with similar avidity target the infected cell population (as shown in Figure 1B), the spread5
of either partly or fully eﬀective escape mutation causes the corresponding CTL clone to contract, since
it recognizes infected cells less eﬃciently than other CTL clones (see Equation S5 in Text S2). Because
infected cells continue to be recognized by other CTL clones, the population of infected cells does not
grow out of control following the escape mutation. Thus, the model reproduces the three-phase dynamics
that can be inferred from kinetic data in HIV infected individuals including the waning of CTL responses
to escaped epitopes [11,13,30,31].
The escape rate of a mutant strain is determined by the loss of CTL recognition and the
loss of viral ﬁtness
Escape mutations begin to be selected once CTL reach suﬃciently high levels (third phase in Figure 1B).
Mutations in all targeted epitopes begin to grow simultaneously, albeit with diﬀerent rates due to variation
in the amounts of ﬁtness and recognition losses caused by a mutation. The exponential growth rates
(escape rates) of mutant strains determine which mutant strain will have most selective advantage and
grow to dominate the population. Here we describe the growth of a mutated strain (Ii) with a single
mutation in epitope 1. An escape mutation results in both a fractional ﬁtness cost, ∆fi, and a fractional
loss of CTL recognition, ∆ri. The mutant strain begins to grow as Ii(t)=Ii(0)e￿it, with initial growth
rate ￿i:
￿i =
1
Ii
dIi
dt
= kEtot
￿
∆ri
n1
− ∆fi
￿
− dI∆fi (1)
where 1/n1 is the fraction of CTL population recognizing epitope 1 (see Text S1). Thus, the escape rate
reﬂects the balance between the partial recognition loss and the partial ﬁtness loss, which determines
whether a mutant strain has a selective advantage (￿>0). In order to infer, for example, the underlying
ﬁtness cost of an escape mutation, it is necessary to measure not only the escape rate, but also the
fraction of the total CTL recognition that is abrogated by the mutation.
When multiple epitopes are targeted and recognition and ﬁtness losses vary across epitopes, the growth
rates of escape mutants vary as well (Figure 1B). In data from HIV infected individuals, it is observed
that the rate of escape slows dramatically over the ﬁrst 100 days post infection [11–13]. The rise of escape
mutants predicted by the model is consistent with these ﬁndings (Figure S2). Furthermore, assuming
only a minor ﬁtness cost, the entire observed variation of escape rates over time and across sites can be6
simulated from the variation of the recognition loss, ∆r.
The trajectory of escape mutations in the cost-beneﬁt plane (∆r, ∆f)
The process of gradual viral escape from the immune response of an infected host continues for years. At
the same time, the virus has only a limited set of viable escape mutations (102 − 103). We investigate
the trajectory connecting these escape mutations in the cost-beneﬁt plane and predict how the average
ﬁtness costs and recognition losses incurred by an escape mutation will change as escape progresses. For
this aim, we use a simpliﬁed version of the main model (see Model ), focused only on the order of escape
mutations (i.e., model dynamics are not considered explicitly). Parameters ∆r and ∆f are randomly
generated for a genome with multiple epitopes and multiple sites per epitope (10 epitopes, with 10 sites
per epitope in Figure 2) and epitope sites are ranked in the descending order of escape rate (Equation
1). When many random runs are compared, a correlation between ∆r and ∆f for escape mutations of a
given rank is observed (Figure 2A). The average trajectory of escape in the cost-beneﬁt plane moves from
high recognition loss, low ﬁtness cost to low recognition loss, high ﬁtness cost. The maximum escape rate
per epitope decreases over many rounds of escape (Figure 2B) and each epitope escapes at more than one
site. This prediction is consistent with experimental observation, where the majority of escaping epitopes
undergo more than one mutation [13,30].
The dynamic interplay between CTL and partially eﬀective escape mutations shape the overall course
of HIV escape. As mentioned above, an escape mutation results in the decay of the cognate CTL
population. In turn, the CTL decay causes the beneﬁt of other escape mutations in the escaping epitope
(in terms of recognition loss) to decrease, because the overall CTL pressure on the epitope is lessened.
The presence or absence of CTL decay has observable consequences for the trajectory of escape mutations
in the cost-beneﬁt plane. Without the CTL decay, the average slope of the trajectory stays constant over
time until no more escapes are possible (Figure 2A). In contrast, when CTL clones decay in response
to the recognition loss, the trajectory bends towards X-axis (Figure 2C) as early escape in an epitope
causes escape mutations on the other sites in that epitope to become progressively less advantageous.
Therefore, a decreased number of escape mutations per epitope is observed when CTL decay is included
in the model (fewer steps in Figure 2D as compared to Figure 2B).7
Weak correlation between ∆r and ∆f has been observed in the Pol gene
The simulation example in Figure 2 oﬀers an interpretation of the work by Mostowy et al [26], where a
weak but statistically signiﬁcant correlation was observed between ﬁtness costs and HLA binding losses
in clinically derived Pol sequences. The existence of the correlation follows from Equation 1, which states
that more costly mutations will not appear unless they confer a large beneﬁt to the virus. The model
relates the weak strength of the correlation (slope = -0.12 between the ﬁtness decrease and the impairment
of HLA binding) to the large number of active epitopes. The existence of the CTL decay caused by escape
can further reduce the slope: mutations sampled during the acute phase of HIV infection are predicted to
have a much larger slope than those sampled during the chronic phase (Figure 3B). Since the majority of
database sequences used in the cited work fall into the latter category, the small slope of the correlation
observed can (at least partially) be caused by CTL decay.
There is an important caveat which must be considered when comparing the model with the cited
work [26]. Loss of CTL recognition in the model is given by ∆r, which is a composite parameter
comprising changes in antigen processing, presentation and recognition, whereas Mostowy et al use the
computationally predicted loss of HLA-epitope binding, ∆B. To convert the units (at least approxi-
mately), we analyzed data from several publications in which both overall loss of CTL recognition as well
as HLA binding impairment was measured [27–29]. We found strong correlation between ∆r and ∆B
expressed as a linear relationship ∆B =0 .78∆r −0.004 (Figure S4, Equations S10 - S14), which justiﬁes
the comparison between the model and the data (see Text S5 for details).
Three patterns of antigenic escape in an epitope with two sites
Epitopes with many sites can produce diﬀerent combinations of escape mutations (haplotypes) in response
to CTL pressure. In [30] it was observed that the mutated sequence changed over time in the majority
of epitopes that were studied longitudinally and, interestingly, the order in which escape haplotypes
appeared varied from epitope to epitope. We divide the epitopes into three characteristic patterns, based
on the order of dominant haplotypes: “simple”, “nested” and “leapfrog”. We can illustrate these patterns
in an epitope with two sites, in which four haplotypes are possible. The presence or absence of an escape
mutation at each site is denoted by a 1 or a 0, respectively. The infrequently observed “simple” pattern
is characterized by a single escape haplotype. For example, in an epitope with two sites, the sequence of
haplotypes observed is 00 → 10. The “nested” escape adds a new mutation sequentially to a previously8
mutated sequence: 00 → 10 → 11. This pattern is predicted if mutations at both sites are under a
constant, positive selection pressure (￿>0 throughout the course of infection). The “leapfrog” pattern
is characterized by a switch in the dominant single-site mutation: 00 → 10 → 01. In the present model,
the leapfrog pattern of escape arises due to time-dependent CTL selection pressure. Below we use the
model to determine the distribution of ﬁtness and recognition losses within an epitope that produces the
leapfrog pattern of escape.
In order to study intra-epitope dynamics, we use the main model (Equations 6 to 8) and consider a
genome composed of a large number of two-site epitopes. This simple case can be studied in detail, and
the results can illustrate the general case, where epitopes are comprised of many sites. We use Equation 1
to determine the escape rates for each of the three mutant haplotypes has for a given level of CTL clone
Ej recognizing epitope j:
￿10 = kEtot
￿
∆r1
nj(t)
− ∆f1
￿
(2)
￿01 = kEtot
￿
∆r2
nj(t)
− ∆f2
￿
(3)
￿11 = kEtot
￿
∆r1 +∆ r2 − ∆r1∆r2
nj(t)
− (∆f1 +∆ f2 − ∆f1∆f2)
￿
(4)
where 1/nj(t) is the time dependent fraction of the total CTL population comprised by CTL clone Ej
and we have neglected the small parameter dI∆f (Table 1). We consider the case where the initial escape
rate of haplotype 10 in epitope j (￿10) is higher than the initial escape rate of haplotype 01 (￿01).
Once an escape haplotype has reached a suﬃciently high frequency, CTL clone Ej will decay monoton-
ically in time, but the virus load will stay stable, since the population of infected cells will be controlled
by the other CTL clones. As 1/nj(t) decreases and the CTL-induced pressure on the epitope declines, the
ﬁtness losses at the two sites, ∆fi, begin to dominate the escape rates (Equations 2 - 4), and the favored
haplotype will change. Eventually, the decay of the CTL clone will cause the transmitted haplotype (00)
to regain ﬁtness advantage and become a dominant strain again (the existence of compensatory mutations
may cause stabilization of the last escaped clone, see Discussion). The sequence of dominant haplotypes
can follow one of the patterns, as follows:
Simple Pattern. The simple pattern of escape (Figure 4A) can occur if the second site cannot escape9
(￿01 < 0, Equation 3). It can also occur if the second site is weakly advantageous, yet the double mutant
(11) does not have time to grow to appreciable frequency before the transmitted haplotype (00) regains
the advantage in growth rate. Observation of this pattern implies a large diﬀerence in the ﬁtness costs
and/or recognition loss magnitudes between the two sites in an epitope.
Leapfrog Pattern. The leapfrog pattern can occur if haplotype 01 gains the advantage over 10 before
the 10 loses the advantage over 00 (Figure 4C and D). In order for this to occur, site 1 must have both
a greater ﬁtness and a greater recognition loss than site 2:
∆r1 > ∆r2,∆f1 > ∆f2 (5)
CTL to the escaping epitope decays at a faster rate during the time period when variant 10 dominates
the population than than during the period when 01 dominates the population. The diﬀerence is due
to the relatively higher recognition loss of the mutation at the ﬁrst site (inset Figure 4D). The exact
conditions required for this pattern are given in Text S3.
Nested Pattern. When both single-mutant haplotypes continue to have a positive growth rate through-
out the course of infection, as in the case of constant selection pressure, the double-mutant haplotype
has the highest escape rate (Figure 4E, F). The nested pattern may occur if the escape rates of both
single-mutant haplotypes are similar (￿10 ∼ ￿01).
We use numeric computation to determine which pattern of escape is observed over a range of recog-
nition and ﬁtness losses at each of the two epitope sites (Text S4). The number of epitopes is ﬁxed, n,
the escape rate for the ﬁrst haplotype, ￿10, and the ratio of the ﬁtness costs in the two epitope sites,
∆f1/∆f2, at values that are representative of acute infection (Figure 5) or chronic infection (Figure S3)
(see Figure S2 for the range of escape rates observed in HIV infected patients). For large escape rates,
the leapfrog pattern can be observed for large values of ∆r1 and a broad range of ∆r2 (Figure 5). Smaller
values of ∆r1 produce smaller escape rates, and the leapfrog is observed in a narrow range of small ∆r2
(Figure S3). In some cases, haplotype 11 is observed as a short intermediate between haplotypes 10 and
01 (labeled “nested leapfrog” in Figure 5). The time interval during which a given haplotype dominates
the population depends on parameters of loss and recognition at epitope site, ∆fk and ∆rk.T h e l e s s
costly haplotype can dominate the population from months to years (shown as t01 in the inset of Fig-
ures S3 and 5). CTL to the escaping epitope will decay at the fastest rate when variant 11 dominates10
the population (inset of Figure 4F).
Model
Model of HIV Dynamics
We model SIV/HIV evolution in the presence of multiple CTL clones (Figure 1A). Each CTL clone
recognizes a distinct viral epitope that is presented by an infected cell. Mutations occur in the proviral
genomes of infected cell that allow an infected cell to partially evade CTL recognition, but come at a cost
in terms of viral replication. The model is given by the following equations:
dT
dt
= λ − dTT − βT
￿
i
fiIi (6)
dIi
dt
= βTfiIi − dIIi − κIi
￿
j
rijEj (7)
dEj
dt
= σ + cEj
￿
i
rijIi
hj +
￿
i rijIi
− dEEj (8)
where fi and rij are the relative viral replication rate of viral genome i and the relative CTL recognition
of sequence i by clone j, as compared to the transmitted sequence, respectively:
fi ≡ exp

−
￿
j,k
sjkai
jk

 (9)
rij ≡ exp
￿
−
￿
k
αjkai
jk
￿
(10)
The processes described are, as follows. Target cells (T) are replenished at a rate λ cells per day, die
with a rate dT and are infected by virus at a rate that depends on the ﬁtness on the infecting strain, with
maximum rate per cell β, and the number of productively infected cells (Ii) in the system. We consider
n epitopes, each consists of m amino acid positions (sites), giving a total of 2mn possible strains. An cell
infected is labeled by proviral genome i with n epitopes denoted gi = ei
1,e i
2,...,e i
n, where each epitope,
ei
j, has m sites ai
j1,a i
j2,...,a i
jm, and a ∈ 0,1 indicates the presence or absence of a mutation at an epitope
site. The ﬁtness of genome i is reduced by mutations. A mutation in epitope j at site k contributes cost11
sjk to the logarithm of the reduction in replication rate. The strain with all 0 is the transmitted strain,
which has ﬁtness 1.
Eﬀector CTL (Ej) are replenished with a constant rate σ cells per day, divide with a rate dependent
on the number of infected cells that they recognize and their avidity, 1/hj, with maximum rate c, and die
with rate dE. CTL clones each respond to a distinct viral epitope that is presented by an infected cell and
kill infected cells at a maximum rate κ. The recognition ability of the CTL clone to epitope j in strain i is
reduced by mutations, as given by Equation 10. A mutation in epitope j at site k contributes αjk to the
logarithm reduction in CTL recognition. In the present work, we assume CTL of equal avidities, hj ≡ h.
Throughout the text, we describe the relative loss in ﬁtness and recognition due to escape mutations in
terms of notation ∆rij ≡ 1 − rij and ∆fi ≡ 1 − fi.
Mutations are generated randomly with rate µ =3·10−5 per site per generation of infected cells (i.e.,
the average lifespan of an infected cell, 1/dI) between strains that diﬀer by one site. Strains with average
copy number above one infected cell are simulated deterministically according to the above equations;
below this threshold a strain is considered extinct. The basic model with one escape-conferring site per
epitope (m = 1) has been introduced by Althaus and De Boer [14]. In this work, we adapt the model
to focus on the eﬀect of partial recognition and ﬁtness losses during a narrow time interval after acute
infection (see Discussion for a detailed comparison of the two models). Further information on model
parameters and the estimated range of parameter values are listed in Table 1.
Following the original work [14], the model assumes that the majority of infected cells are killed by
CTL rather than by viral cytopathicity. It has also been proposed that CTL decrease the viral production
in infected cells in a non-lytic fashion, and that cells die within a ﬁxed period of time (∼ 24h) due to viral
cytopathicity [33]. A speciﬁc choice of the mechanism of infected cell death (CTL or viral cytopathicity)
is not likely to aﬀect the main conclusions about the dynamics of CTL escape. Furthermore, due to the
existence of the eclipse phase of viral production, it is diﬃcult to distinguish between these mechanisms
using data from in vivo studies [34,35]. Thus, we prefer to use the CTL-induced death model, which is
simpler to implement and easier to support immunologically.
Simpliﬁed model to study the order of escape mutations
We introduce a simpliﬁed model, which does not explicitly consider dynamics, in order to study the
sequence of escape mutations for a realistic size genome. Fractional ﬁtness costs (∆f) and recognition12
losses (∆r) are randomly generated from a uniform distribution [0,1] for 100 sites (10 epitopes with
10 sites per epitope) in order to study the sequence of escaped sites. All sites are ranked in order of
∆r − ∆f · n and escape sites in similar ranking over many runs are considered together. CTL decay is
introduced for all additional sites in an epitope once a site in the epitope escapes: after each round of
escape, ∆r is reduced for all sites in the epitope by: ∆r(n + 1) = ∆r(n)exp[−d￿
E
￿
i ∆ri(0)] for all i in
the epitope that have escaped. Here parameter d￿
E is deﬁned as the decay rate per escape, in contrast to
dE in the main model which is deﬁned per day.
Discussion
The recent availability of time-resolved, deep-sequencing data from HIV infected patients have illuminated
the complexity of interaction between CTL clones and the genetically diverse HIV population. Using a
model including multiple CTL clones, we demonstrate that the rate of viral escape depends on both the
partial recognition losses and ﬁtness costs associated with an escape mutation as well as the number of
active CTL clones. Furthermore, the model predicts that CTL populations change their relative sizes
in response to viral escape, which has observable consequences for the sequence and number of escape
mutations that are possible over time. Changing selection pressure on an epitope due to declining CTL
levels can also cause the dominant escape variant in an epitope to change in a non-nested fashion. The
model contains several assumptions and simpliﬁcations, as follows.
Pre-existing mutations. We assume that the population of infected cells in acute infection and steady
state is large, so that all single escape mutants exist in the population before the rise of CTL (as in [14,15]).
The assumption is supported by estimates of the large eﬀective HIV population size [4,36,37]. We can also
infer the fact of preexistence of CTL escape mutations from the observed preexistence of drug-resistant
mutations evident in the early emergence of resistance to mono-therapy (e.g. [38]). Furthermore, since
the number of escape mutations per epitope is typically larger than the number of drug resistance sites
per drug, the mutation cost of the least costly escape mutation can be assumed to be lower – and the
frequency of preexisting mutations higher – for escape mutations. The preexistence of single mutants
casts doubts on the interpretation of very late escape mutations as the result of the late appearance of
an escape mutation not initially present in the population [39].13
Eventual reversion to the wild type is prevented by compensatory mutations. Mutations compensating
for ﬁtness losses are widely spread in HIV genome [43], including drug-resistance mutations [40–42] and
immune-escape mutations [10,19,20]. They have been hypothesized to be a major driving force of HIV
evolution and high diversity [44]. However, the dynamics of compensation remains poorly understood.
Therefore, our model does not explicitly include compensatory mutations and, as a result, predicts
the eventual reversion of any escape mutation with a ﬁtness cost. Instead of including compensation,
we calculate the period of time that a given mutation would be maintained in the population before
reversion occurs, which is the same time interval where compensation would be necessary in order to
prevent reversion (inset of Figures 5 and S3). When the non-nested pattern of escape is observed in
infected patients, the ﬁrst escape variant is typically short-lived compared to the second escape variant,
and the transmitted variant is not observed after the initial escape [11,30,31]. Our interpretation is that
the ﬁtness cost of the ﬁrst variant is large relative to the second variant and does not have time to be
compensated before the second variant gains the advantage. The second variant either has a very small
ﬁtness cost or is compensated gradually during its lifetime (compensation is not explicitly simulated). Our
calculation of the lifetimes of diﬀerent escape variants in an epitope is a ﬁrst step towards understanding
the timescales associated with compensation.
Multiple CTL clones of equal avidity. The present analysis is focused on the ﬁrst year post-infection,
the time interval in which most escape mutations occur. Therefore, we consider a group of CTL clones
with similar avidities that are present initially in similar numbers. This is a reasonable assumption after
escape mutations have occured in the ﬁrst few immunodominant epitopes during the resolution of acute
viremia. At this time, a large number of CTL clones are activated and are maintained for many months
at simular levels [6,45]. Once all CTL clones are activated, our model predicts that the steady state
viral load is proportional to the inverse avidity of the most avid CTL clone (Equation S2). Kadolsky
and Asquith [46] estimated that the average viral load increases by only 0.051 log copies/ml per CTL
escape. This small increase, which we interpret to be the average diﬀerence avidity spacing between CTL
clones, justiﬁes our assumption that CTL avidities are, indeed, very closely spaced. Our analysis shows
that, given closely spaced avidities, it is recognition and ﬁtness losses that govern the order and timing
of escape mutations, rather than variation in CTL avidity.
Other assumptions. The model includes additional simplifying assumptions, as follows. i) The pro-
liferation rate of CTL clones saturates with the infected cell number, but not with the total CTL level.14
In the original model [14], the authors postulate this saturation to predict that the total number of CTL
limits the growth of individual CTL clones, which causes clones to interact and enables the co-existence
of multiple CTL clones with diﬀerent avidities. We believe that further study is needed to verify the
existence and the possible origin of the interclonal interaction. (Note that the target availability may
not be the cause of interclonal interaction, because most CTL are not bound to their targets even at the
peak of infection, and the overall eﬀector to target ratio is less than two [47].) ii) CTL are short-lived
in the absence of antigen, with an average lifetime of 10 days, as is consistent with early studies of CTL
dynamics in SIV system [48,49] and mathematical modeling of these data [50]. iii) We ignore recombi-
nation, which may increase the rate of emergence of escape mutations among diﬀerent epitopes [15] as
well as the long term rate of evolution [51,52]. For the intra-epitope dynamics of escape, recombination
between neighboring sites will be a small correction. (iv) CTL clones against escape mutants are not
included in the model. By including partial rather than full recognition loss, we allow CTL to escaped
epitopes to continue to exert selection pressure without incorporating additional CTL clones. Though
clones to escape mutants may exist, introducing extra CTL clones (5 clones for each two-site epitope,
instead of 1) would complicate analysis of the model without changing the essential results. (v) Small
ﬁtness costs are assumed. Equation 1 states that costly escapes ∆f ∼ 1 cannot arise when recognition
losses are partial and many CTL clones target the viral genome. We choose to focus on the time interval
corresponding to the ﬁrst year after the resolution of acute infection when these assumptions are fulﬁlled.
Escape mutations entailing a high ﬁtness cost can only escape when only one or two CTL clones dominate
strongly, which we estimate from previous data to be during the 3-4 weeks post-infection. (vi) Fitness
costs are positive. A fraction of mutations that are transmitted to an individual that fall outside the
individuals HLA-restricted epitopes revert (i.e. may have a negative ﬁtness cost). However, the rate of
reversion is very small [17] and hardly interferes with a faster dynamics of the within-epitope mutations.
(vii) We consider escape processes in diﬀerent epitopes separately, because typically they do not overlap
much in time. In general, however, linkage eﬀects (clonal interference, background selection) between
epitope mutations and compensatory mutations of same or diﬀerent epitopes may complicate the picture
(see [32] for review of recent research in this area).
Thus, our model has demonstrated that partial recognition losses, in addition to ﬁtness costs and
the breadth of the CTL response, dramatically aﬀect the rate and the order of escape mutations during
an HIV infection. These ﬁndings help to interpret the positive correlation between ﬁtness costs and15
recognition losses observed in the Pol gene [26] and make the testable prediction that the strength of
the correlation should decrease with the time post-infection. Our results call for direct measurements
of recognition losses for diﬀerent escape mutations. Combined with the proposed trajectory approach
(Figure 2), these data will serve as a basis for improved prediction of conserved epitopes for use in
vaccines.
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Table 1. Model Parameters
Parameter Realistic Value Description Reference
n 1- 8 Number of epitopes recognized during ﬁrst 100
days
[11,13,30,31]
m 2 - 10 Number of sites per epitope important for recog-
nition
[11,13,30,31]
dT 1d −1 Target cell death rate [50,53]
λ/dT 5 · 108 cells Activated target cell level [50,54,55]
dI 1d −1 Virus-induced infected cell death rate [56] ￿
j κEss
j 4d −1 CTL-induced infected cell death rate [50,54,55]
β 1.1 · 10−8(d · cell)
−1 Basic eﬃciency of target cell infection [50,54,55]
s [0 −∞ ] Intrinsic mutation cost [10,21,22,27–29]
α [0 −∞ ] Reduction of CTL recognition [27–29]
∆fi [0 − 1] Fractional reduction in intrinsic replication rate
∆rij [0 − 1] Fractional reduction of CTL recognition
κ 1 · 10−9(d · cell)
−1 CTL killing eﬃciency. Gives 108 − 109 CTLs in
chronic infection
[48]
σ/dE 103 cells Initial population of CTLs [54]
c 1d −1 Maximum growth rate of eﬀector cells [54]
dE 0.1 d−1 Death rate of eﬀector cells [50,54,55]
hj 2.5 · 108 cells Number of recognized infected cells for half maxi-
mal proliferation of CTL (inverse avidity). Gives
an infected cell level of 107−108 in chronic infec-
tion
[47]
Model parameters for the model of escape from multiple CTL shown in Figure 1.31
Figure 1. A computational model of the interaction between HIV and multiple CTL
clones. (A) The model given by Equations 6 to 8 comprises three interacting cell compartments: target
cells (T), infected cells (I) and multiple CTL clones (E). Viral genomes contain multiple epitopes, which
can mutate to partially abrogate CTL recognition. An escape mutation is denoted by an X. Each CTL
clone recognizes a single viral epitope and is stimulated to divide at a rate proportional to the number
of infected cells with recognizable epitopes. The model is designed to study the rate of escape in
epitopes when CTL pressure is distributed across multiple epitopes, as well as study intra-epitope
escape patterns when CTL respond dynamically to the infected cells that they recognize. Black arrows:
ﬂux of cells from one compartment to another. Blue arrows: dependence of the rate of ﬂux from one
compartment on another. Dotted lines represent attenuation of the interaction strength. (B) Simulation
example showing three phases of HIV evolution. A single virus strain initiates the infection (transmitted
strain, black). In response to the growing number of infected cells, multiple CTL clones are activated
(colored lines), and the system reaches a steady state. Finally, virus strains with escape mutations
(dashed, colored lines) replace the transmitted strain. In response to lowered activation signals, some
CTL clones decline. The escape strains are colored to match the CTL against which an escape was
most recently acquired. Model parameters: number of epitopes, n = 6; number of sites per epitope,
m = 1. Epitopes 1-3 have parameters that allow escape ∆ri =[ 0 .1,0.2,0.3],∆f =0 .01, epitopes 4-6
have parameters that prohibit escape, ∆fi =∆ ri =0 .1. Other parameters are listed in Table 1.
Figure 2. The escape trajectory in the cost-beneﬁt plane bends over time due to CTL
decay. Fitness costs and recognition losses are randomly generated for 100 sites (10 epitopes with 10
sites per epitope) in order to study the sequence of escaped sites (black line) in the whole genome
without CTL decay (A,B) or with CTL decay (C,D) for 1000 simulation runs. (A) For each site that
escapes, the fractional ﬁtness cost, ∆f, multiplied by the number of epitopes, n = 10, and fractional
recognition loss, ∆r) (Equation 1 and Table 1) is shown. Colors show the predicted rank of escape
mutations, from early escape mutations (blue) to late escape mutations (red). The average trajectory
over all runs (black) moves from high recognition loss, low ﬁtness cost to low recognition loss, high
ﬁtness cost. Inset: The best-ﬁt slope for each escape rank. A positive correlation is observed between
the ﬁtness and recognition losses for all epitopes that escape at a given rank. (B) The maximum escape
rate of any epitope site for all 10 epitopes for a representative simulation run. (C-D) As in (A-B),
except including CTL decay. CTL decay is simulated by reducing recognition losses for all epitope sites
in epitopes that have partially escaped according to ∆r(n + 1) = ∆r(n)exp[−d￿
E
￿
i ∆ri(0)], summing
over all i sites in the epitope that have escaped with d￿
E =0 .1 per escape . When CTLs decay in
response to lost recognition caused by an escape in an epitope, the immune pressure and hence the
recognition loss for all other sites in that epitope is decreased. The result is that the average trajectory
in the cost-beneﬁt plane bends towards the horizontal axis.32
Figure 3. Fitness loss and recognition losses of escape mutations are predicted to
correlated positively, with a slope that deceases in time. Sites are randomly sampled from the
simulation described in the caption to Figure 2 in order to simulate the eﬀect of acute samples (high
ranking sites), late chronic samples (low ranking sites) or patient samples from random times (random
ranks). (A) No CTL decay. The slope of the correlation from acute (blue) or late chronic (red) sampled
escape mutations is the same, however, it is lower for escape mutations sampled at random times
(green). (B) CTL decay causes the slope of the correlation to decrease in time, due to decrease of CTL
selection pressure. CTL decay is introduced as described in the caption to Figure 2 and Model.
Figure 4. Dynamical selection pressure from CTLs causes three possible patterns of
intra-epitope escape: example for an epitope with two sites. Intra-epitope escape in one
epitope with two sites is studied for the model shown in Figure 1 and Model.T h es e q u e n c ei nw h i c h
haplotypes are selected depends on the distribution of ﬁtness and recognition losses within an epitope.
The fraction of the infected cell population containing each of the four haplotypes in the escaping
epitope is shown in for “simple” (A), “leapfrog” (C) and “nested” pattern (E). For each pattern, the
dependence of the escape rate (Equations 2 - 4) for each haplotype on the fraction of CTLs responding
to the epitope (B, D, F) . The inset shows CTL dynamics: the size of the CTL clone to escaping epitope
(red) and the total CTL number (black). Parameters: (A,B) ∆r1k =[ 0 .4,0.1],∆f1k =[ 0 .01,0.01], (C,D)
∆r1k =[ 0 .6,0.2],∆f1k =[ 0 .1,0.003], (E,F) ∆r1k =[ 0 .4,0.25],∆f1k =[ 0 .003,0.003] with n = 2, m =2
for all panels; other parameters are given in Table 1.
Figure 5. The pattern of emergence of escape variants in a single epitope contains
information about the fraction of recognition and ﬁtness lost by single-site mutations in
the epitope. The pattern of escape (Figure 4) is obtained from simulation of the model (Figure 1,
Equations 6 to 8) with two sites per epitope, m = 2 for a range of recognition and ﬁtness losses. The
pattern that is obtained is plotted as a function of the parameters of recognition loss at the ﬁrst and
second site (∆r1 and ∆r2, respectively). Equations S6 (red line) and S9 (blue line) determine the region
where the leapfrog pattern can be observed. Regions that require ∆f1 < 0 are not allowed by deﬁnition
(magenta line). The shaded regions between these three lines correspond to regions of parameter space
where both sites escape. The corresponding patterns are: “leapfrog” (10 → 01, Figure 4C), “nested”
(10 → 11, Figure 4E), “nested leapfrog” (10 → 11 → 01). Observation of the leapfrog pattern in an
epitope tightly constrains the fraction of CTL recognition loss conferred by sites in an epitope. The
inset shows the length of time during which haplotype 01 is dominant in the escaping epitope. Fixed
parameters are: the escape rate of the ﬁrst haplotype (￿10 =0 .5) and the number of targeted epitopes
(n = 3), values which correspond to escape mutations that occur in acute infection (see Figure S3 for
parameters that correspond to later in infection). Fitness costs are chosen such that the second site is
less costly than the ﬁrst: ∆f1/∆f2 equal to 3 (A) or much less costly than the ﬁrst, ∆f1/∆f2 = 10 (B).
Other parameters given in Table 1.33
Figure S1. Changing composition of CTL and infected cell populations. Simulation of model
given by Equations 6 to 8 with the same parameters as in Figure 1B. (A) Escape mutations in viral
epitopes spread through the population of infected cells to abrogate CTL recognition. Once the system
has reached steady state, the number of infected cells is roughly constant, and the prevalence of an
escape mutation can be measured as a fraction of the total infected cell population. (B) Once an escape
mutation has spread to the majority of infected cells, the corresponding CTL clone begins to decay with
a rate proportional to the fraction of recognition lost. Since the total CTL population remains roughly
constant in steady state, the prevalence of a given CTL clone can be shown as a fraction of the total
CTL population.
Figure S2. Escape rate and t50 are negatively correlated in two experimental studies. The
frequency of a mutated epitope for epitopes over time is ﬁt to the curve f(t)={1+e x p [ −￿(t − t50)]}−1,
which describes deterministic selection on a single site with selection coeﬃcient ￿, in order to determine
parameters ￿ and t50. Colored dots show data from a single patient studied in [11] (blue) and multiple
patients studied in [30] CH40 (red), CH58 (green), CH77 (cyan). Inset: Simulation example showing
the correlation between escape rate, ￿, and the time that the mutation spreads to 50% of the population
of infected cells, denoted t50. Parameters ￿ and t50 are found for the three escape mutations shown in
Figure 1B that occur in the ﬁrst 200 days post infection. Thus, variation in recognition and ﬁtness
losses across many epitopes successfully reproduces this feature of escape dynamics.
Figure S3. CTL lifetime changes the frequency with which intra-epitope escape patterns
are observed Here we show a modiﬁed version of Figure 5 for the case when CTL are long-lived,
dE =0 .01 (other parameters are the same as Figure 5). When CTLs are long-lived, the leapfrog pattern
(Figure 4C)) is observed more often, since the haplotype 01 has time to grow to dominate the
population. / Here, the death rate of CTL is dE =0 .01, ten times smaller than the value used in
Figure 5. The diﬀerence between the predicted leapfrog region as determined by Equations S6 (red line)
and S9 (blue line) and the shaded region where leapfrog is actually observed is lessened for long-lived
CTL. This is the case because each time that haplotype 01 gains the advantage over haplotype 10, it
grows to dominate the population before CTL decay to the level where haplotype 01 also reverts.
Figure S4. Estimating the relationship between ∆r and ∆B approximately from three
published experiments. Our model contains one parameter for CTL recognition loss caused by a
mutation, ∆r. In order to compare model predictions with data from Mostowy et al [26], where HLA
binding impairment caused by mutations was considered rather than overall CTL recognition loss, we
sought to compare HLA binding impairment with overall CTL recognition loss. By combine data from
three references, Schneidewind et al [27], Kawashima et al [28] and Matthews et al [29], we were able to
demonstrate a strong correlation between the two parameters. This justiﬁes our comparison of our
model predictions with data from [26].
Text S1: Steady state and the escape rate34
Text S2: Escape causes contraction of CTL clones
Text S3: General conditions for observing the leapfrog pattern of escape
Text S4: Simulation: Leapfrog pattern can occur in a broad range of ﬁtness and
recognition losses
Text S5: Finding the relationship between ∆r and HLA binding loss from three diﬀerent
experiments